We all know that historical movies can be inaccurate. Sometimes, they get historical figures completely wrong – for example, Pocahontas was a child when she met John Smith, and so was Isabella of ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Braveheart Bio is a clinical-stage biotechnology company developing novel therapeutics for hypertrophic cardiomyopathy and related conditions. The company is backed by experienced life science ...

Mel Gibson is single and ready to mingle – but only hotties need apply, RadarOnline.com can reveal. The 70-year-old actor is licking his wounds after longtime galpal Rosalind Ross walked out, but he's ...

Gormley’s Irish and International Art Auction features some very unusual items from the estate of artist Jack B Yeats. Video: Bryan O'Brien As smoke rises over Tehran from latest strikes, Trump ...

The bedroom in which Mel Gibson stayed during the filming of Braveheart. Photo: Niall Mullen A rallying cry has gone out to Braveheart fans who fancy getting their hands on some unique items used by ...

Greenlanders have told the Daily Record they will follow the example of Braveheart hero William Wallace to defend their “freedom” in the face of threats from Donald Trump. As the US President vows to ...

The mistake is among a myriad of historical blunders that are shown in the iconic flick THE cult classic Braveheart has been watched and loved endlessly since the 90s – and yet it’s only now that even ...

Bristol Myers Squibb currently has the only drug approved specifically for treating obstructive hypertrophic cardiomyopathy, a debilitating disorder that can progress to heart failure. But safety ...

With $185 million in series A funding and an army of experienced leaders in its ranks, Braveheart Bio is setting off to joust with big names in an emerging heart disease drug arena. Backed by ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min It’s one of the largest ...